Seminars in Hematology
Volume 44, Issue 4 , Pages 227-233 , October 2007

High-Dose Treatment With Autologous Stem Cell Transplantation in Multiple Myeloma: Past, Present, and Future

  • Bo Björkstrand

      Affiliations

    • Corresponding Author InformationAddress correspondence to Bo Björkstrand, MD, PhD, Hematology Center, M54, Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden.
  • ,
  • Gösta Gahrton

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the Swedish Cancer Society and the Stockholm Cancer Society.

PII: S0037-1963(07)00126-6

doi: 10.1053/j.seminhematol.2007.08.010

Seminars in Hematology
Volume 44, Issue 4 , Pages 227-233 , October 2007